A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent - Related Studies

A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent

This study is currently recruiting participants.

Study NCT00668148. Last updated on October 14, 2008. Information provided by ImClone Systems

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Rhabdomyosarcoma
		Leiomyosarcoma
		Adipocytic Sarcoma
		Synovial Sarcoma

2	Additional conditions recognized in this trial
		Neuroectodermal Tumors
		Neuroectodermal Tumors, Primitive, Peripheral
		Sarcoma
		Sarcoma, Ewing's
		Sarcoma, Synovial

3	More general conditions related to this trial
		Myosarcoma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Bone Tissue
		Neoplasms, Connective and Soft Tissue
		Neoplasms, Connective Tissue
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Muscle Tissue
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Neuroectodermal Tumors, Primitive
		Osteosarcoma

4	Interventions listed in this trial
		IMC-A12

5	Sponsors listed in this trial
		ImClone Systems